These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36632949)

  • 1. The cannabinoid CB
    Rivas-Santisteban R; Lillo J; Raïch I; Muñoz A; Lillo A; Rodríguez-Pérez AI; Labandeira-García JL; Navarro G; Franco R
    Exp Neurol; 2023 Apr; 362():114319. PubMed ID: 36632949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB
    Navarro G; Borroto-Escuela D; Angelats E; Etayo Í; Reyes-Resina I; Pulido-Salgado M; Rodríguez-Pérez AI; Canela EI; Saura J; Lanciego JL; Labandeira-García JL; Saura CA; Fuxe K; Franco R
    Brain Behav Immun; 2018 Jan; 67():139-151. PubMed ID: 28843453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of GPR55 and either cannabinoid CB
    Martínez-Pinilla E; Rico AJ; Rivas-Santisteban R; Lillo J; Roda E; Navarro G; Lanciego JL; Franco R
    Brain Struct Funct; 2020 Sep; 225(7):2153-2164. PubMed ID: 32691218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin AT
    Rivas-Santisteban R; Rodriguez-Perez AI; Muñoz A; Reyes-Resina I; Labandeira-García JL; Navarro G; Franco R
    J Neuroinflammation; 2020 Aug; 17(1):243. PubMed ID: 32807174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-DOPA disrupts adenosine A(2A)-cannabinoid CB(1)-dopamine D(2) receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: biochemical and behavioral studies.
    Pinna A; Bonaventura J; Farré D; Sánchez M; Simola N; Mallol J; Lluís C; Costa G; Baqi Y; Müller CE; Cortés A; McCormick P; Canela EI; Martínez-Pinilla E; Lanciego JL; Casadó V; Armentero MT; Franco R
    Exp Neurol; 2014 Mar; 253():180-91. PubMed ID: 24412491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Interactions Involving the Mas Receptor Show Potential of the Renin-Angiotensin system in the Regulation of Microglia Activation: Altered Expression in Parkinsonism and Dyskinesia.
    Rivas-Santisteban R; Lillo J; Muñoz A; Rodríguez-Pérez AI; Labandeira-García JL; Navarro G; Franco R
    Neurotherapeutics; 2021 Apr; 18(2):998-1016. PubMed ID: 33474655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cannabinoid CB
    Martínez-Pinilla E; Rico AJ; Rivas-Santisteban R; Lillo J; Roda E; Navarro G; Franco R; Lanciego JL
    Ann N Y Acad Sci; 2020 Sep; 1475(1):34-42. PubMed ID: 32594556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CB1 and GPR55 receptors are co-expressed and form heteromers in rat and monkey striatum.
    Martínez-Pinilla E; Reyes-Resina I; Oñatibia-Astibia A; Zamarbide M; Ricobaraza A; Navarro G; Moreno E; Dopeso-Reyes IG; Sierra S; Rico AJ; Roda E; Lanciego JL; Franco R
    Exp Neurol; 2014 Nov; 261():44-52. PubMed ID: 24967683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arachidonyl-2'-chloroethylamide (ACEA), a synthetic agonist of cannabinoid receptor, increases CB
    Leija-Salazar M; Bermúdez de León M; González-Horta A; González-Hernández B
    Pharmacol Biochem Behav; 2020 Jul; 194():172950. PubMed ID: 32413434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the Ghrelin and Cannabinoid CB
    Lillo J; Lillo A; Zafra DA; Miralpeix C; Rivas-Santisteban R; Casals N; Navarro G; Franco R
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental parkinsonism.
    Sierra S; Luquin N; Rico AJ; Gómez-Bautista V; Roda E; Dopeso-Reyes IG; Vázquez A; Martínez-Pinilla E; Labandeira-García JL; Franco R; Lanciego JL
    Brain Struct Funct; 2015 Sep; 220(5):2721-38. PubMed ID: 24972960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic L-DOPA treatment increases striatal cannabinoid CB1 receptor mRNA expression in 6-hydroxydopamine-lesioned rats.
    Zeng BY; Dass B; Owen A; Rose S; Cannizzaro C; Tel BC; Jenner P
    Neurosci Lett; 1999 Dec; 276(2):71-4. PubMed ID: 10624794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and functional interaction between GPR18 and cannabinoid CB
    Reyes-Resina I; Navarro G; Aguinaga D; Canela EI; Schoeder CT; Załuski M; Kieć-Kononowicz K; Saura CA; Müller CE; Franco R
    Biochem Pharmacol; 2018 Nov; 157():169-179. PubMed ID: 29870711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The therapeutic role of cannabinoid receptors and its agonists or antagonists in Parkinson's disease.
    Han QW; Yuan YH; Chen NH
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jan; 96():109745. PubMed ID: 31442553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of glutamate release by complexes of adenosine and cannabinoid receptors.
    Köfalvi A; Moreno E; Cordomí A; Cai NS; Fernández-Dueñas V; Ferreira SG; Guixà-González R; Sánchez-Soto M; Yano H; Casadó-Anguera V; Cunha RA; Sebastião AM; Ciruela F; Pardo L; Casadó V; Ferré S
    BMC Biol; 2020 Jan; 18(1):9. PubMed ID: 31973708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Singular Location and Signaling Profile of Adenosine A
    Moreno E; Chiarlone A; Medrano M; Puigdellívol M; Bibic L; Howell LA; Resel E; Puente N; Casarejos MJ; Perucho J; Botta J; Suelves N; Ciruela F; Ginés S; Galve-Roperh I; Casadó V; Grandes P; Lutz B; Monory K; Canela EI; Lluís C; McCormick PJ; Guzmán M
    Neuropsychopharmacology; 2018 Apr; 43(5):964-977. PubMed ID: 28102227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ghrelin and Cannabinoid Functional Interactions Mediated by Ghrelin/CB
    Lillo A; Lillo J; Raïch I; Miralpeix C; Dosrius F; Franco R; Navarro G
    Front Cell Neurosci; 2021; 15():786597. PubMed ID: 34955755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties.
    García-Arencibia M; González S; de Lago E; Ramos JA; Mechoulam R; Fernández-Ruiz J
    Brain Res; 2007 Feb; 1134(1):162-70. PubMed ID: 17196181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential upregulation of the cannabinoid CB₂ receptor in neurotoxic and inflammation-driven rat models of Parkinson's disease.
    Concannon RM; Okine BN; Finn DP; Dowd E
    Exp Neurol; 2015 Jul; 269():133-41. PubMed ID: 25895887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting CB
    Martínez-Pinilla E; Aguinaga D; Navarro G; Rico AJ; Oyarzábal J; Sánchez-Arias JA; Lanciego JL; Franco R
    Mol Neurobiol; 2019 Aug; 56(8):5900-5910. PubMed ID: 30687889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.